STING1 and cancer: In this work, the GSH/NIR sequentially initiated gas nanoadjuvant with AIEgen-mediated PDT/PTT synergistic therapy and tumor-specific amplified H2S/CO/Mn2+ generation is constructed to effectively invade cancer cells and significantly activate cGAS-STING pathway for poorly immunogenic TNBC treatment.